These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 34981997)

  • 1. Transcriptomic Analysis of Breast Cancer Patients Sensitive and Resistant to Chemotherapy: Looking for Overall Survival and Drug Resistance Biomarkers.
    Barrón-Gallardo CA; Garcia-Chagollán M; Morán-Mendoza AJ; Delgadillo-Cristerna R; Martínez-Silva MG; Aguilar-Lemarroy A; Jave-Suárez LF
    Technol Cancer Res Treat; 2022; 21():15330338211068965. PubMed ID: 34981997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digital gene expression profiling analysis and its application in the identification of genes associated with improved response to neoadjuvant chemotherapy in breast cancer.
    Liu X; Jin G; Qian J; Yang H; Tang H; Meng X; Li Y
    World J Surg Oncol; 2018 Apr; 16(1):82. PubMed ID: 29685151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptomic Profiling Identifies Differentially Expressed Genes in Palbociclib-Resistant ER+ MCF7 Breast Cancer Cells.
    Lanceta L; O'Neill C; Lypova N; Li X; Rouchka E; Waigel S; Gomez-Gutierrez JG; Chesney J; Imbert-Fernandez Y
    Genes (Basel); 2020 Apr; 11(4):. PubMed ID: 32344635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Methylation Markers and Differentially Expressed Genes with Prognostic Value in Breast Cancer.
    Wu J; Zhang Y; Li M
    J Comput Biol; 2019 Dec; 26(12):1394-1408. PubMed ID: 31290690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
    Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
    Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross‑validation of genes potentially associated with neoadjuvant chemotherapy and platinum‑based chemoresistance in epithelial ovarian carcinoma.
    Zhang K; Wang W; Chen L; Liu Y; Hu J; Guo F; Tian W; Wang Y; Xue F
    Oncol Rep; 2020 Sep; 44(3):909-926. PubMed ID: 32705213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptome Analysis Identifies GATA3-AS1 as a Long Noncoding RNA Associated with Resistance to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer Patients.
    Contreras-Espinosa L; Alcaraz N; De La Rosa-Velázquez IA; Díaz-Chávez J; Cabrera-Galeana P; Rebollar-Vega R; Reynoso-Noverón N; Maldonado-Martínez HA; González-Barrios R; Montiel-Manríquez R; Bautista-Sánchez D; Castro-Hernández C; Alvarez-Gomez RM; Jiménez-Trejo F; Tapia-Rodríguez M; García-Gordillo JA; Pérez-Rosas A; Bargallo-Rocha E; Arriaga-Canon C; Herrera LA
    J Mol Diagn; 2021 Oct; 23(10):1306-1323. PubMed ID: 34358678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Candidate Genes Associated with Breast Cancer Prognosis.
    Xu YH; Deng JL; Wang LP; Zhang HB; Tang L; Huang Y; Tang J; Wang SM; Wang G
    DNA Cell Biol; 2020 Jul; 39(7):1205-1227. PubMed ID: 32456464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant Regulation of RAD51 Promotes Resistance of Neoadjuvant Endocrine Therapy in ER-positive Breast Cancer.
    Jia Y; Song Y; Dong G; Hao C; Zhao W; Li S; Tong Z
    Sci Rep; 2019 Sep; 9(1):12939. PubMed ID: 31506496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-platform meta-analysis of multiple gene expression profiles identifies novel expression signatures in acquired anthracycline-resistant breast cancer.
    Lee YS; Ryu SW; Bae SJ; Park TH; Kwon K; Noh YH; Kim SY
    Oncol Rep; 2015 Apr; 33(4):1985-93. PubMed ID: 25695524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Expression Profiles of lncRNAs Are Associated with Neoadjuvant Chemotherapy Resistance in Locally Advanced, Luminal B-Type Breast Cancer.
    González-Woge M; Contreras-Espinosa L; García-Gordillo JA; Aguilar-Villanueva S; Bargallo-Rocha E; Cabrera-Galeana P; Vasquez-Mata T; Cervantes-López X; Vargas-Lías DS; Montiel-Manríquez R; Bautista-Hinojosa L; Rebollar-Vega R; Castro-Hernández C; Álvarez-Gómez RM; De La Rosa-Velázquez IA; Díaz-Chávez J; Jiménez-Trejo F; Arriaga-Canon C; Herrera LA
    Int J Mol Sci; 2024 Jul; 25(15):. PubMed ID: 39125649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive and prognostic impact of ferroptosis-related genes ACSL4 and GPX4 on breast cancer treated with neoadjuvant chemotherapy.
    Sha R; Xu Y; Yuan C; Sheng X; Wu Z; Peng J; Wang Y; Lin Y; Zhou L; Xu S; Zhang J; Yin W; Lu J
    EBioMedicine; 2021 Sep; 71():103560. PubMed ID: 34482070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD2 Is a Novel Immune-Related Prognostic Biomarker of Invasive Breast Carcinoma That Modulates the Tumor Microenvironment.
    Chen Y; Meng Z; Zhang L; Liu F
    Front Immunol; 2021; 12():664845. PubMed ID: 33968066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A ferroptosis-associated gene signature for the prediction of prognosis and therapeutic response in luminal-type breast carcinoma.
    Peng Y; Yu H; Zhang Y; Qu F; Tang Z; Qu C; Tian J; Zong B; Wang Y; Ren H; Liu S
    Sci Rep; 2021 Sep; 11(1):17610. PubMed ID: 34475496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Novel Biomarkers Associated With the Prognosis and Potential Pathogenesis of Breast Cancer via Integrated Bioinformatics Analysis.
    Wu M; Li Q; Wang H
    Technol Cancer Res Treat; 2021; 20():1533033821992081. PubMed ID: 33550915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemo-resistant Gastric Cancer Associated Gene Expression Signature: Bioinformatics Analysis Based on Gene Expression Omnibus.
    Liu JB; Jian T; Yue C; Chen D; Chen W; Bao TT; Liu HX; Cao Y; Li WB; Yang Z; Hoffman RM; Yu C
    Anticancer Res; 2019 Apr; 39(4):1689-1698. PubMed ID: 30952707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Network-based approach to identify prognosis-related genes in tamoxifen-treated patients with estrogen receptor-positive breast cancer.
    Wang Y; Gong X; Zhang Y
    Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34406386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting the immune landscape of invasive breast carcinoma based on the novel signature of immune-related lncRNA.
    Shen S; Chen X; Hu X; Huo J; Luo L; Zhou X
    Cancer Med; 2021 Sep; 10(18):6561-6575. PubMed ID: 34378851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of miRNA Signature in Breast Cancer to Predict Neoadjuvant Chemotherapy Response.
    Xing AY; Wang B; Li YH; Chen X; Wang YW; Liu HT; Gao P
    Pathol Oncol Res; 2021; 27():1609753. PubMed ID: 34257614
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.